Edition:
United States

Boule Diagnostics AB (BOUL.ST)

BOUL.ST on Stockholm Stock Exchange

260.00SEK
8:02am EST
Change (% chg)

-0.50kr (-0.19%)
Prev Close
260.50kr
Open
257.00kr
Day's High
263.00kr
Day's Low
257.00kr
Volume
160
Avg. Vol
13,639
52-wk High
378.00kr
52-wk Low
240.00kr

Chart for

About

Boule Diagnostics AB is a Sweden-based company engaged in the provision of medical diagnostic and testing equipment. The Company specializes in the development, manufacture and sale of complete blood count (CBC) systems in the field of hematology. It provides reagents, cleaning products and blood calibrators and controls that... (more)

Overall

Beta: 1.09
Market Cap(Mil.): kr1,252.00
Shares Outstanding(Mil.): 4.81
Dividend: 1.40
Yield (%): 0.54

Financials

  Industry Sector
P/E (TTM): -- 28.23 15.25
EPS (TTM): -- -- --
ROI: -- 10.01 33.27
ROE: -- 15.21 16.35

BRIEF-Boule Diagnostics Q3 operating profit grows to SEK ‍28.2​ mln

* Q3 NET SALES SEK ‍109.7​ MILLION VERSUS SEK 108.5 MILLION YEAR AGO

Nov 08 2017

BRIEF-Boule Diagnostics appoints ‍christina Rubenhag new CFO

* ‍CHRISTINA RUBENHAG NEW CFO FROM OCT.9 2017 Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Sep 20 2017

BRIEF-Boule Diagnostics Q2 net result swings to loss SEK 1.1 mln

* Q2 NET SALES SEK ‍104.3​ MILLION VERSUS SEK 102.0 MILLION YEAR AGO

Aug 25 2017

Earnings vs. Estimates